Concentrix Corporation Common Stock (CNXC) is a publicly traded Technology sector company. As of May 21, 2026, CNXC trades at $25.15 with a market cap of $1.46B and a P/E ratio of -1.18. CNXC moved +2.53% today. Year to date, CNXC is -41.60%; over the trailing twelve months it is -55.65%. Its 52-week range spans $22.05 to $66.00. Analyst consensus is strong buy with an average price target of $44.33. Rallies surfaces CNXC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Concentrix Targets $100M AI ARR, Projects 12.5% FY2026 Margin: Concentrix reported 6% revenue declines in both its technology, consumer electronics and healthcare verticals in Q1, with margins compressed until the second half of fiscal 2026. The company ended Q4 with $60 million in AI ARR, aims for $100 million by year-end and targets a 12.5% operating margin.
| Metric | Value |
|---|---|
| Price | $25.15 |
| Market Cap | $1.46B |
| P/E Ratio | -1.18 |
| EPS | $-21.07 |
| Dividend Yield | 0.36% |
| 52-Week High | $66.00 |
| 52-Week Low | $22.05 |
| Volume | 23 |
| Avg Volume | 0 |
| Revenue (TTM) | $9.95B |
| Net Income | $-1.33B |
| Gross Margin | 34.45% |
3 analysts cover CNXC: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $44.33.